Efficient site-specific integration in CHO-K1 cells using CRISPR/Cas9-modified donors
Author:
Funder
Tehran University of Medical Sciences and Health Services
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11033-023-08529-8.pdf
Reference27 articles.
1. Walsh G, Walsh E (2022) Biopharmaceutical benchmarks. Nat Biotechnol 40:1722–1760
2. Tihanyi B, Nyitray L (2021) Recent advances in CHO cell line development for recombinant protein production. Drug Discov Today Technol. https://doi.org/10.1016/j.ddtec.2021.02.003
3. Shin SW, Lee JS (2020) CHO cell line development and engineering via site-specific integration: challenges and opportunities. Biotechnol Bioprocess Eng. https://doi.org/10.1007/s12257-020-0093-7
4. Lee JS, Kildegaard HF, Lewis NE, Lee GM (2019) Mitigating clonal variation in recombinant mammalian cell lines. Trends Biotechnol 37(9):931–942
5. Banan M (2020) Recent advances in CRISPR/Cas9-mediated knock-ins in mammalian cells. J Biotechnol 308:1–9
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CHO cell engineering via targeted integration of circular miR-21 decoy using CRISPR/RMCE hybrid system;Applied Microbiology and Biotechnology;2024-08-09
2. Study on chromatin regulation patterns of expression vectors in the PhiC31 integration site;Epigenetics;2024-04-09
3. Recombinant therapeutic proteins degradation and overcoming strategies in CHO cells;Applied Microbiology and Biotechnology;2024-01-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3